Fund Houses Update - 08 December 2025

 

Dear Trader...

Fund Houses Recommendations

• GS on KIMS: Initiate Buy on Company, target price at Rs 900/Sh (Positive)
• GS on Max Health: Initiate Buy on Company, target price at Rs 1325/Sh (Positive)
• Nuvama on Sona BLW: Maintain Buy on Company, target price at Rs 750/Sh (Positive)
• MS on Suzlon: Maintain Overweight on Company, target price at Rs 78/Sh (Positive)
• Kotak on Tata Capital: Initiate Add on Company, target price at Rs 360/Sh (Positive)
• MS on Bajaj Finance: Maintain Overweight on Company, target price at Rs 1195/Sh (Positive)
• Emkay on Fino Payment Bank: Maintain Add on Company, raise target price at Rs 330/Sh (Positive)
• Avendus on Biocon: Maintain Add on Company, target price at Rs 435/Sh (Positive)
• Citi on India Strategy: Citi says bank NIMs near cyclical trough, sees room for MCLR and deposit rate cuts, and expects ₹50,000 cr–₹1 lakh cr OMOs in 4QFY26; prefers AU SFB, RBL, SBI and BoB (Positive)
• GS on India Strategy: RBI’s 25 bps rate cut to 5.25%, lower inflation forecasts and stronger growth outlook; expects limited further cuts unless US-tariff risks persist into CY26 (Neutral)
• GS on Biocon: Maintain Neutral on Company, target price at Rs 375/Sh (Neutral)
• Jeeferies on Indigo: Maintain Buy on Company, target price at Rs 7025/Sh (Neutral)
• UBS on Indigo: Maintain Buy on Company, cut target price at Rs 6350/Sh (Neutral)
• JP Morgan on Bajaj Finance: Maintain Neutral on Company, target price at Rs 1040/Sh (Neutral)
• Investec on Indigo: Company must comply with the new FDTL norms by 10 February 2026. Bad just goes worse, cut target price at Rs 4040/Sh (Negative)
• JM FIn on Indigo: Passing turbulence could lead to some lasting cost pressures (Negative)

Warm Regards...

Nikhil Bhatt
Business Editor
Investment Point
Contact :- 99390 80808
www.nikhilbhatt.in

Join Channel :- https://whatsapp.com/channel/0029Va6EjWxA2pL2q3fKm035

The securities quoted are for illustration only and are not recommendatory. Investment in securities market are subject to market risks. Read and agree Disclaimer and related all the documents carefully before investing, mentioned on www.nikhilbhatt.in